Ex-Vyera CEO Criticizes Shkreli At Drug-Pricing Bench Trial
Former Vyera Pharmaceuticals CEO Eliseo Salinas told a Manhattan federal judge Tuesday that he thinks Martin Shkreli's 2015 move to dramatically jack up the price of an anti-parasitic drug the company...To view the full article, register now.
Already a subscriber? Click here to view full article